USPTO 2015–2025 USPTO PatentsView US Corporation

Shukla Medical

USPTO PatentsView assignee record — 121 granted patents across 11 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

121
Total patents granted
11
CPC technology areas
5.8
Avg claims per patent
+900%
5-year filing velocity

The verdict

Shukla holds 121 US patents across 11 technology areas — rank #3,126 of 50,000 tracked assignees.

#3,126
of 50,000 US assignees by volume
Top 25%
by Innovation Score (44.6/100)
5.8
avg claims per patent
+900%
filing velocity, last 5 yrs

Portfolio overview

Shukla Medical has been granted 121 US utility patents between 2017 and 2025, placing Shukla Medical at rank #3,126 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Shukla Medical is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 110 grants, compared with 11 in the 2015–2019 window — a +900% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Shukla Medical's 5.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Shukla Medical against peers pursuing similar technology classes.

How does Shukla compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Shukla holds 121 patents — placing it at rank #3,126 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Shukla's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

010203040 201720182019202020212022202320242025 7
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Shukla Medical patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 7 5.8%
2018 2 1.7%
2019 2 1.7%
2020 4 3.3%
2021 30 24.8%
2022 17 14.0%
2023 25 20.7%
2024 27 22.3%
2025 7 5.8%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,126

Across all tracked assignees

Innovation Score

44.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Shukla Medical hold?
Shukla Medical holds 121 US granted patents filed between 2017 and 2025, spanning 11 technology areas.
What is Shukla Medical's Innovation Score?
Shukla Medical has an Innovation Score of 44.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Shukla Medical focus on?
Shukla Medical's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 24 patents. The company has filed patents in 11 CPC subclasses total.
Is Shukla Medical's patent filing rate increasing or decreasing?
Shukla Medical's recent filing velocity is +900% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Shukla Medical's patents?
Shukla Medical's patents average 5.8 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Shukla Medical patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope